Brief: Abionyx Pharma Publishes H1 Net Income Of 2.9 Million Euros

Abionyx Pharma SA

06/09/2019 18:28

Sept 6 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX DID NOT GENERATE ANY REVENUES IN THE FIRST HALF OF
2019
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 9.62 MILLION AT
30
JUNE 2019
    * DECREASE IN H1 RESEARCH AND DEVELOPMENT EXPENSES, WHICH
AMOUNTED
TO €325 THOUSAND FOR THE PERIOD
    * H1 NET INCOME EUR 2.9 MILLION VERSUS LOSS EUR 3.4 MILLION
YEAR
AGO
    * H1 OPERATING  LOSS  EUR 1.5 MILLION VERSUS LOSS EUR 3.0
MILLION
YEAR AGO

Source text for Eikon:  ID:nNDL4Mm7T 
Further company coverage:  ABNX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))